Tetrylammonium

Tetrylammonium

SCHEMBL36945

CC[N+](CC)(CC)CC.O=P([O-])(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNA1 known ✓ Q09470 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
KDM4E B2RXH2 1/20 0.47
PMP22 Q01453 1/20 0.47
ATM Q13315 1/20 0.47
SLC34A1 Q06495 1/20 0.47
CA2 P00918 1/20 0.33
MMP1 P03956 3/20 0.32
MMP2 P08253 3/20 0.32
FDPS P14324 5/20 0.32
LAP3 P28838 1/20 0.32
BBOX1 O75936 2/20 0.31
GGPS1 O95749 2/20 0.31
LPAR3 Q9UBY5 3/20 0.31
MMP3 P08254 2/20 0.31
MMP8 P22894 2/20 0.31
LPAR2 Q9HBW0 1/20 0.31
MMP9 P14780 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL36854 0.94 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL7118391 0.91 TSHR (0.47) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL9335566 0.91 TSHR (0.47) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL11015403 0.87 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL36855 0.87 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL1478382 0.87 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL7131133 0.84 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL9335570 0.84 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL9333160 0.84 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL28300822 0.84 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079810-A Aromatic diamine and polyimide containing amido, preparation method and application thereof 2026-05-26 CN claimed
US-20260066324-A1 REDOX CYCLABLE MOLECULES FOR ENERGY STORAGE MICROSOFT TECHNOLOGY LICENSING LLC (US) 2026-03-05 US claimed
EP-4690281-A1 COMPOSITION FOR TIN HARD MASK REMOVAL WHILE COMPATIBLE WITH TUNGSTEN Versum Materials US, LLC (US) 2026-02-11 EP claimed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
US-20250381519-A1 CO2 CONCENTRATOR AND RELATED MATERIALS, PROCESSES, AND SYSTEMS SUSTEON INC (US) 2025-12-18 US claimed
WO-2024233437-A1 COMPOSITION FOR TIN HARD MASK REMOVAL WHILE COMPATIBLE WITH TUNGSTEN VERSUM MATERIALS US, LLC (US) 2024-11-14 WO claimed
CN-117987853-A Co-production method of adiponitrile and 1,3, 6-hexanetrinitrile 山东省天大君昊化工技术有限公司 2024-05-07 CN claimed
CN-116196970-A Catalyst for preparing olefin from methanol, preparation method thereof and method for reacting methanol to olefin 国家能源投资集团有限责任公司 2023-06-02 CN claimed
US-20200261857-A1 MeAPO-18 Membranes with Lamellar Crystal Morphology and Their Preparation TOTAL RESEARCH & TECHNOLOGY FELUY (BE) 2020-08-20 US claimed
EP-3664921-A1 MEAPO-18 MEMBRANES WITH LAMELLAR CRYSTAL MORPHOLOGY AND THEIR PREPARATION Total Research & Technology Feluy (BE) 2020-06-17 EP claimed
US-6620983-B1 Forming reaction mixture comprising sources of aluminum and phosphorus, organic template, compound comprising two or more fluorine substituents and capable of providing fluoride ions, and, optionally, source of silicon, inducing crystallization EXXONMOBIL CHEMICAL PATENTS INC. 2003-09-16 US claimed
US-20030092951-A1 Process for the synthesis of silicoaluminophosphate molecular sieves MERTENS MACHTELD M (BE) 2003-05-15 US claimed
US-6514899-B1 Process for the synthesis of silicoaluminophosphate molecular sieves EXXONMOBIL CHEMICAL PATENTS, INC. 2003-02-04 US claimed
EP-1222145-A1 PROCESS FOR THE SYNTHESIS OF SILICOALUMINOPHOSPHATE MOLECULAR SIEVES ExxonMobil Chemical Patents Inc. (US) 2002-07-17 EP claimed
EP-1140743-A1 CATALYTIC PROCESS FOR THE PREPARATION OF LIGHT OLEFINS FROM METHANOL IN A FLUIDISED BED REACTOR Casale Chemicals SA (CH) 2001-10-10 EP claimed
WO-2001025150-A1 PROCESS FOR THE SYNTHESIS OF SILICOALUMINOPHOSPHATE MOLECULAR SIEVES POP, GRIGORE 2001-04-12 WO claimed
WO-2001025151-A1 PROCESS FOR THE SYNTHESIS OF SILICOALUMINOPHOSPHATE MOLECULAR SIEVES EXXON CHEMICAL PATENTS, INC. (US) 2001-04-12 WO claimed
WO-2000041986-A1 CATALYTIC PROCESS FOR THE PREPARATION OF LIGHT OLEFINS FROM METHANOL IN A FLUIDISED BED REACTOR CASALE CHEMICALS S.A. (CH) 2000-07-20 WO claimed
US-4399007-A APPLYING POTENTIAL, CATALYST SELECTIVITY LEVER BROTHERS COMPANY (US) 1983-08-16 US claimed
US-4326932-A Hydrogenation LEVER BROTHERS COMPANY (US) 1982-04-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260066324-A1 REDOX CYCLABLE MOLECULES FOR ENERGY STORAGE CYBB, SCO2, NOX4 KCNA1 259/4885TSHR 2942/4885NFKB1 2826/4885
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 KCNA1 585/4885TSHR 2647/4885NFKB1 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.